Feb 28, 2017
Stuart Cain, a researcher at UBC’s Michael Smith Laboratories, was quoted in the Daily Mail about research on the drug Lyrica.
Cain said the drug, used to treat epilepsy, shows promise for treating migraines, although its efficacy is unclear.
An information source that gives journalists access to UBC’s expertise.